In 1995, the National Institutes of Health (NIH) developed a new classification of prostatitis and proposed a corresponding treatment: Type I: equivalent to the traditional classification of acute bacterial prostatitis (ABP), the main treatment is broad-spectrum antibiotics, symptomatic treatment and supportive therapy, mostly using intravenous infusion therapy. This type of patient is less common clinically. Type II: equivalent to chronic bacterial prostatitis (CBP) in the traditional classification method, with oral sensitive antibiotics as the main treatment and a course of 4 to 6 weeks. This type accounts for about 5% to 8% of patients with chronic prostatitis. Type III: Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS), equivalent to CNP and PD in the traditional classification method, is the most common type of prostatitis, accounting for about 90% or more of chronic prostatitis. The type can be subdivided into 2 subtypes, IIIA (inflammatory CPPS) and IIIB (non-inflammatory CPPS), with IIIA and IIIB accounting for about 50% each. Type IIIA: Oral antibiotics can be given for 2 to 4 weeks, and then the decision to continue antibiotic therapy is based on the treatment effect. Alpha-blockers, non-steroidal anti-inflammatory analgesics, phytochemicals, M-blockers, etc. can be used in combination. Type IIIB: Antibiotic treatment is not advocated; α-blockers, NSAIDs, phytochemicals, M-blockers and other drugs can be chosen for treatment. Type IV: asymptomatic prostatitis (AIP), also known as histological prostatitis, has no clinical symptoms and generally does not require treatment. From the above information, it can be seen that only about half of the patients with prostatitis need to be treated with antibiotics, but in real clinical practice, the therapeutic effect of antibiotics is greatly reduced due to some of the following reasons: 1. The prostate gland has an envelope and the drug does not penetrate easily; 2. The prostate gland has poor local tissue blood supply and the effective drug concentration is not well maintained; 3. The degree of ionization of the drug, lipid solubility, protein The degree of ionization, lipid solubility, protein binding rate, relative molecular mass and molecular structure of the drug affect the therapeutic effect. If the drug is not fat-soluble, it is difficult to penetrate into the prostate; 4. Clinically, only about 5% of patients with chronic prostatitis have a clear bacterial infection. Unfortunately, there is a tendency to abuse antibiotics in the current clinical prostatitis treatment due to various factors. The treatment mechanism is not directly targeting the prostate gland and microorganisms such as bacteria, but rather the overall comprehensive regulation of the body state, increasing immune function, relieving symptoms and curing the disease. In addition, the acupuncture and moxibustion methods in Chinese medicine are quite effective in treating type III chronic prostatitis, especially chronic pelvic pain syndrome; and the traditional qigong methods can improve the symptoms of chronic prostatitis and enhance sexual function. If you are interested, you may want to give it a try, as long as you stick to it for a period of time, you will definitely get satisfactory results. Of course, the main thing is that the actual results of the treatment will give you an answer: satisfied or unsatisfied!